CareDx, Inc. (CDNA)
Nasdaq: CDNA · Services-Medical Laboratories · Brisbane, CA · filing with the SEC since 2003
Grade5.2
◀ Past 4.9● Present 5.2▶ Future 5.6
Who owns CareDx, Inc.
As filed with the SECHolders of 5% or more
1
Blackrock, Inc. holds 9% of Common Stock, as its SCHEDULE 13G/A filed Jul 27, 2026 says.
Directors and officers
13
report now, of 37 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 27, 2026 · Common Stock · 8% in Apr 17, 2025
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK · reported falling below 5%, from 5.3% in Feb 9, 2026
ARK Investment Management LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock · reported falling below 5%, from 5.67% in Jan 10, 2025
Neil Gagnon
SCHEDULE 13G/A · filed Aug 7, 2026 · Common Stock · reported falling below 5%, from 5.9% in Feb 12, 2026
Baron Capital Group, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock · reported falling below 5%, from 5.93% in Nov 14, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 7.04% in Oct 30, 2025
What CDNA reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 25, 2026.
Insider tradesForm 4
36sales
0purchases
28sales on a scheduled plan
8people selling
$18.4Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 39 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Hanna John Walter Jr | President and CEO | 11 | $7.5M | 11 | 0 | $0 |
| Kennedy Keith | CFO & COO | 8 | $4.8M | 8 | 0 | $0 |
| Goldberg Michael | director | 1 | $2.1M | 0 | 0 | $0 |
| Valantine Hannah | director | 3 | $1.3M | 3 | 0 | $0 |
| Bickerstaff George | director | 1 | $900,000 | 0 | 0 | $0 |
| Cournoyer Christine | director | 1 | $800,000 | 1 | 0 | $0 |
| Novack Jeffrey Adam | Secretary and General Counsel | 9 | $700,000 | 5 | 0 | $0 |
| Torres Arthur A | director | 2 | $200,000 | 0 | 0 | $0 |